Search anything
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Tanla Platforms’ Q4 FY26 results are expected in May 2026, with the market tracking revenue and PAT estimates, margins, and any final dividend recommendation.
Tanla Platforms’ Q4 FY26 results are expected in May 2026, with Street revenue estimates of ₹1,040-1,120 crore and PAT of ₹205-225 crore after Q3 revenue of ₹1,121 crore.
Adisoft Technologies’ SME IPO opened April 23 with a ₹163-172 band, GMP near ₹10, mixed lot-size chatter online, and valuation talk around 13x P/E.
US stocks traded mixed with Nasdaq at a record, as Intel’s upbeat Q2 revenue forecast and falling bond yields offset Iran-war uncertainty and Dow weakness.
Dr. Reddy’s launched Obeda, India’s first DCGI-approved generic semaglutide injection, priced at Rs 4,200 per month, targeting wider access to GLP-1 therapy for type 2 diabetes.
Reliance Industries reported a 12.6% YoY fall in Q4FY26 profit as West Asia-driven energy costs hit margins, even as FY26 sales crossed ₹10 trillion.
Amagi Media Labs listed on 21 January 2026 below its ₹361 issue price, opening near ₹318 and trading up to ₹356-357 before ending around ₹348.
Social media is pushing a Nifty 50 ETF “buy 1% dip from all-time high” rule, but data, FY2026 outcomes, and current levels show SIPs stay hard to beat.
Finance Minister Nirmala Sitharaman said the IDBI Bank disinvestment will continue, easing uncertainty after reserve price concerns and triggering an intraday rally in the stock.
JPMorgan downgraded Indian equities to neutral, cut Nifty targets and flagged valuation premium, earnings downgrades, dilution risk, and limited AI-sector exposure amid macro uncertainties.
Shriram Finance shares rose 9.4% after MUFG Bank’s ₹39,618 crore preferential allotment, with rating agencies citing stronger capital, cheaper funding and improved liquidity expectations.
Lodha Developers posted Q3 FY26 pre-sales of INR56.2 billion, backed by INR35.6 billion collections, while starting an NCR pilot and reaffirming its INR210 billion FY26 target.
OneSource Specialty Pharma rose up to 5% as its partner secured tentative US FDA approval for a generic Ozempic ANDA, even as recent margins and revenue trends stayed mixed.
Mukesh Ambani said Jio Platforms is moving toward an IPO and a first-half 2026 listing, as the business posted 19% full-year EBITDA growth and higher quarterly profit.
Supreme Petrochem reported a 63% YoY rise in Q2 FY26 profit to ₹148 crore even as revenue fell to ₹1,117 crore, and investors await the next earnings update on 24 April 2026.
Can Fin Homes expects a March-quarter rebound with ₹3,200-3,300 crore disbursals, holds a 3.75% NIM target, and sees FY26 credit cost potentially below 10 bps.
